He, F., Kessi, M., Zhang, C., Peng, J., Yin, F., & Yang, L. The utilization of the multimodal immunotherapy for the opsoclonus–myoclonus syndrome can reduce relapses and permanent neurological sequelae. BMC.
Chicago Style (17th ed.) CitationHe, Fang, Miriam Kessi, Ciliu Zhang, Jing Peng, Fei Yin, and Lifen Yang. The Utilization of the Multimodal Immunotherapy for the Opsoclonus–myoclonus Syndrome Can Reduce Relapses and Permanent Neurological Sequelae. BMC.
MLA (9th ed.) CitationHe, Fang, et al. The Utilization of the Multimodal Immunotherapy for the Opsoclonus–myoclonus Syndrome Can Reduce Relapses and Permanent Neurological Sequelae. BMC.
Warning: These citations may not always be 100% accurate.